http://www.forbes.com/forbeslife/health/feeds/hscout/2007/04/25/hscout604023.html

FDA Probing Data on Antipsychotic Drug Zyprexa

The U.S. Food and Drug Administration is investigating whether Eli
Lilly & Company provided accurate data about the safety of the
antipsychotic drug Zyprexa, The New York Times reported.

Concerns about the drug's link to diabetes and weight gain have
contributed to a 50 percent decline in the number of Zyprexa
prescriptions written in the United States since 2003.

The FDA wants to find out more about a Feb. 2000 Lilly document that
noted that patients taking Zyprexa in clinical trials had a 3.5 times
greater risk of developing high blood sugar than people who didn't
take the drug. That document was not given to the FDA, The Times
reported.

A few months later, Lilly submitted data to the FDA showing similar
blood sugar levels in patients who took Zyprexa and in those who
didn't take the drug.

The FDA told The Times that it's still looking into the matter and has
not yet decided whether to take any action against Lilly.

***